SUPPLEMENTAL TABLE 2.
Baseline demographic and clinical characteristics
| CHARACTERSITICS | STUDY 1 | STUDY 2 | ||
|---|---|---|---|---|
| E-BPO CREAM, 5% (N=243) |
VEHICLE (N=118) |
E-BPO CREAM, 5% (N=250) |
VEHICLE (N=122) |
|
| Age, years | ||||
| Mean (SD) | 52.8 (13.21) | 52.4 (13.26) | 49.5 (14.04) | 51.5 (12.55) |
| Median (range) | 54.0 (19–81) | 52.5 (24–85) | 50.0 (18–79) | 53 (22–84) |
| Sex, n (%) | ||||
| Male | 60 (24.7) | 35 (29.7) | 69 (27.6) | 35 (28.7) |
| Female | 183 (75.3) | 83 (70.3) | 181 (72.4) | 87 (71.3) |
| Race, n (%) | ||||
| American Indian/Alaska Nat. | 0 | 0 | 0 | 2 (1.6) |
| Asian | 9 (3.7) | 2 (1.7) | 20 (8.0) | 8 (6.6) |
| Black/African American | 0 | 0 | 2 (0.8) | 0 |
| Nat. Hawaiian/Pac. Islander | 0 | 0 | 3 (1.2) | 2 (1.6) |
| White | 233 (95.9) | 116 (98.3) | 220 (88.0) | 110 (90.2) |
| Multiple/Other | 1 (0.4) | 0 | 5 (2.0) | 0 |
| Ethnicity, n (%) | ||||
| Hispanic/Latino | 86 (35.4) | 39 (33.1) | 55 (22.0) | 30 (24.6) |
| Not Hispanic or Latino | 156 (64.2) | 77 (65.3) | 195 (78.0) | 92 (75.4) |
| Unknown | 1 (0.4) | 2 (1.7) | 0 | 0 |
| IGA severity (%) | ||||
| Moderate | 210 (86.4) | 104 (88.1) | 227 (90.8) | 112 (91.8) |
| Severe | 33 (13.6) | 14 (11.9) | 23 (9.2) | 10 (8.2) |
| Lesion count | ||||
| Mean (SD) | 25.7 (11.07) | 26.3 (12.45) | 29.8 (14.00) | 27.5 (13.04) |
| Median (range) | 22.0 (15–69) | 21.0 (15–70) | 25.0 (15–70) | 22.5 (15–70) |
E-BPO: encapsulated benzoyl peroxide; IGA: Investigator Global Assessment; Nat.: native; Pac.: Pacific; SD: standard deviation